Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial.
Abstract: Two horse farms, on which there was a high incidence of proven and suspected equine degenerative myeloencephalopathy (EDM), were studied. Symmetric ataxia and paresis, along with laryngeal adductor, cervicofacial, local cervical, and cutaneous trunci hyporeflexia, characterized the syndrome. Serum vitamin E concentration reflected a deficient state in affected and unaffected horses on both farms when compared with selected reference groups and with published values. A high incidence of the disease was evident in offspring of two particular sires on one farm. Vitamin E supplementation resulted in correction of the deficient state in most horses and was associated with a drastic reduction in the incidence of EDM on one farm from 40% to less than 10% the year following vitamin E supplementation. In addition, during the last year, the severity of signs in the few cases was dramatically reduced. This information substantiates the hypothesis that EDM is a vitamin E-responsive disorder of Equidae with a possible familial predisposition.
Publication Date: 1987-01-01 PubMed ID: 3506620DOI: 10.1111/j.1939-1676.1987.tb01985.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The abstract focuses on research conducted on two horse farms with notably high incidences of equine degenerative myeloencephalopathy (EDM), a disease that was found to be linked to vitamin E deficiency and potentially hereditary traits. Vitamin E supplementation significantly lessened the prevalence and severity of the disease.
Research Context and Objective
- The goal of this study was to investigate the unusually high occurrence of equine degenerative myeloencephalopathy (EDM) on two horse farms and ascertain potential causes and solutions to the issue. EDM, a neurological disorder, was characterized by symptoms such as symmetric ataxia (lack of muscle control), paresis (weakness), and different types of hyporeflexia (below-normal reflexes).
Critical Findings
- The study discovered that all horses, regardless of whether they were affected by EDM, demonstrated vitamin E deficiency when their serum vitamin E levels were compared to a selected reference group and published data.
- The study observed that the disease appeared quite frequently in the offspring of two sires (male parents) on one of the farms. This pointed towards a potential hereditary predisposition towards EDM.
- A large part of the horses showed a return to the normal vitamin E levels upon supplementation, which was associated with a significant decrease in the prevalence of EDM on the farm — from 40% to less than 10% in the following year. The severity of symptoms also lessened greatly in the remaining cases in the last year of the research.
Conclusions
- The findings support the hypothesis that EDM is a vitamin E-responsive disorder within the horse family, with a possible familial predisposition. This implies that vitamin E deficiency could be a direct cause of EDM, and supplementation could serve as a successful intervention.
- Additionally, the pattern of disease occurrence in the offspring of certain sires hints at a genetic predisposition to the deficiency and consequently, the disease. Further studies could help in identifying the specific genetic factors that make horses susceptible to EDM.
Cite This Article
APA
Mayhew IG, Brown CM, Stowe HD, Trapp AL, Derksen FJ, Clement SF.
(1987).
Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial.
J Vet Intern Med, 1(1), 45-50.
https://doi.org/10.1111/j.1939-1676.1987.tb01985.x Publication
Researcher Affiliations
- Department of Medical Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610.
MeSH Terms
- Animals
- Ataxia / genetics
- Ataxia / veterinary
- Brain Diseases / drug therapy
- Brain Diseases / genetics
- Brain Diseases / veterinary
- Brain Stem / pathology
- Female
- Horse Diseases / genetics
- Horses
- Male
- Paralysis / genetics
- Paralysis / veterinary
- Reflex, Abnormal / genetics
- Reflex, Abnormal / veterinary
- Spinal Cord Diseases / drug therapy
- Spinal Cord Diseases / genetics
- Spinal Cord Diseases / veterinary
- Vitamin E / therapeutic use
- Vitamin E Deficiency / drug therapy
- Vitamin E Deficiency / genetics
- Vitamin E Deficiency / veterinary
Citations
This article has been cited 20 times.- Powers A, Peek SF, Reed S, Donnelly CG, Tinkler S, Gasper D, Woolard KD, Finno CJ. Equine neuroaxonal dystrophy/degenerative myeloencephalopathy in Gypsy Vanner horses. J Vet Intern Med 2024 May-Jun;38(3):1792-1798.
- Palmisano M, Kulp J, Bender S, Stefanovski D, Robinson M, Johnson A. Measurement of 8-hydroxy-2'-deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia. J Vet Intern Med 2024 Mar-Apr;38(2):1207-1213.
- Ma Y, Peng S, Donnelly CG, Ghosh S, Miller AD, Woolard K, Finno CJ. Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy. J Vet Intern Med 2024 Jan-Feb;38(1):417-423.
- Hales EN, Habib H, Favro G, Katzman S, Sakai RR, Marquardt S, Bordbari MH, Ming-Whitfield B, Peterson J, Dahlgren AR, Rivas V, Ramirez CA, Peng S, Donnelly CG, Dizmang BS, Kallenberg A, Grahn R, Miller AD, Woolard K, Moeller B, Puschner B, Finno CJ. Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy. J Vet Intern Med 2021 Sep;35(5):2473-2485.
- Hales EN, Esparza C, Peng S, Dahlgren AR, Peterson JM, Miller AD, Finno CJ. Genome-Wide Association Study and Subsequent Exclusion of ATCAY as a Candidate Gene Involved in Equine Neuroaxonal Dystrophy Using Two Animal Models. Genes (Basel) 2020 Jan 10;11(1).
- Marquardt SA, Wilcox CV, Burns EN, Peterson JA, Finno CJ. Previously Identified Genetic Variants in ADGRL3 Are not Associated with Risk for Equine Degenerative Myeloencephalopathy across Breeds. Genes (Basel) 2019 Sep 5;10(9).
- Burns EN, Finno CJ. Equine degenerative myeloencephalopathy: prevalence, impact, and management. Vet Med (Auckl) 2018;9:63-67.
- Finno CJ, Estell KE, Winfield L, Katzman S, Bordbari MH, Burns EN, Miller AD, Puschner B, Tran CK, Xu L. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy. J Vet Intern Med 2018 Sep;32(5):1740-1747.
- Finno CJ, Bordbari MH, Valberg SJ, Lee D, Herron J, Hines K, Monsour T, Scott E, Bannasch DL, Mickelson J, Xu L. Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes. Free Radic Biol Med 2016 Dec;101:261-271.
- Finno CJ, Miller AD, Sisó S, Divers T, Gianino G, Barro MV, Valberg SJ. Concurrent Equine Degenerative Myeloencephalopathy and Equine Motor Neuron Disease in Three Young Horses. J Vet Intern Med 2016 Jul;30(4):1344-50.
- Díez de Castro E, Zafra R, Acevedo LM, Pérez J, Acosta I, Rivero JL, Aguilera-Tejero E. Eosinophilic Enteritis in Horses with Motor Neuron Disease. J Vet Intern Med 2016 May;30(3):873-9.
- Finno CJ, Estell KE, Katzman S, Winfield L, Rendahl A, Textor J, Bannasch DL, Puschner B. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy. J Vet Intern Med 2015 Nov-Dec;29(6):1667-75.
- Finno CJ, Valberg SJ, Shivers J, D'Almeida E, Armién AG. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization. Vet Pathol 2016 Jan;53(1):77-86.
- Ulatowski L, Parker R, Warrier G, Sultana R, Butterfield DA, Manor D. Vitamin E is essential for Purkinje neuron integrity. Neuroscience 2014 Feb 28;260:120-9.
- Finno CJ, Famula T, Aleman M, Higgins RJ, Madigan JE, Bannasch DL. Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse. J Vet Intern Med 2013 Jan-Feb;27(1):177-85.
- Delguste C, de Moffarts B, Kirschvink N, Art T, Pincemail J, Defraigne JO, Amory H, Lekeux P. Change in blood antioxidant status of horses moved from a stable following diagnosis of equine motor neuron disease. Can Vet J 2007 Nov;48(11):1165-7.
- Mohammed HO, Divers TJ, Summers BA, de Lahunta A. Vitamin E deficiency and risk of equine motor neuron disease. Acta Vet Scand 2007 Jul 2;49(1):17.
- Adams AP, Collatos C, Fuentealba C, Illanes O, Blanchard R. Neuroaxonal dystrophy in a two-year-old quarter horse filly. Can Vet J 1996 Jan;37(1):43-4.
- Cummings JF, de Lahunta A, Mohammed HO, Divers TJ, Summers BA, Valentine BA, Jackson CA. Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases. Acta Neuropathol 1995;90(3):266-72.
- de Lahunta A. Abiotrophy in domestic animals: a review. Can J Vet Res 1990 Jan;54(1):65-76.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
